Sinocelltech Group Limited (SHA:688520)

China flag China · Delayed Price · Currency is CNY
73.50
+5.05 (7.38%)
Aug 15, 2025, 2:45 PM CST
107.92%
Market Cap 32.60B
Revenue (ttm) 2.42B
Net Income (ttm) 101.52M
Shares Out 445.34M
EPS (ttm) 0.21
PE Ratio 321.10
Forward PE 135.56
Dividend n/a
Ex-Dividend Date n/a
Volume 14,905,262
Average Volume 7,902,204
Open 68.00
Previous Close 68.45
Day's Range 66.11 - 76.20
52-Week Range 31.07 - 89.04
Beta 0.85
RSI 56.40
Earnings Date Aug 29, 2025

About Sinocelltech Group

Sinocelltech Group Limited, a biotech company, engages in the research and development, and industrialization of recombinant proteins, monoclonal antibodies, and innovative vaccines in China. The company offers Anpingxi an antibody drug and anti-tumor product; Anjiayin for the treatment of the rare disease hemophilia A; coronavirus 2-valent, a trimer protein vaccine; and mutant strain recombinant protein vaccines SCTV01C and SCTV01E. Its pipeline products include SCT630 used for the treatment of autoimmune diseases; SCT510 for the treatment of ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2007
Employees 2,277
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688520
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.